{"mainPropery":{"diseaseId":7639,"diseaseName":"Sialidosis type I","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/7639/sialidosis-type-i","synonyms":["Cherry red spot myoclonus syndrome","Myoclonus cherry red spot syndrome"],"synonyms-with-source":[{"name":"Cherry red spot myoclonus syndrome"},{"name":"Myoclonus cherry red spot syndrome"}],"identifiers":[{"identifierType":"OMIM","identifierId":"256550"},{"identifierType":"ORPHANET","identifierId":"812"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":37,"resourceName":"Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)","abbreviation":"","address1":"#218-2055 Commercial Drive ","address2":"Vancouver, BC V5N OC7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"604-924-5130","tty":"","tollFree":"800-667-1846","fax":"604-924-5131","email":"info@mpssociety.ca","url":"http://www.mpssociety.ca","freeText":""},{"resourceID":209,"resourceName":"National MPS Society","abbreviation":"","address1":"P.O. Box 14686 ","address2":"","address3":"","address4":"","address5":"","city":"Durham","state":"NC","zip":"27709-4686","country":"United States","phone":"+1-919-806-0101","tty":"","tollFree":"1-877-MPS-1001 (1-877-677-1001)","fax":"+1-919-806-2055","email":"info@mpssociety.org","url":"https://mpssociety.org/","freeText":""},{"resourceID":210,"resourceName":"Society for Mucopolysaccharide (MPS) Diseases","abbreviation":"","address1":"MPS House Repton Place White Lion Road","address2":"Amersham Buckinghamshire","address3":"HP7 9LP","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"(+44) 0345 389 9901 ","tty":"","tollFree":"","fax":"","email":"mps@mpssociety.co.uk","url":"http://www.mpssociety.co.uk","freeText":""},{"resourceID":318,"resourceName":"Hide and Seek Foundation for Lysosomal Storage Disease Research","abbreviation":"","address1":"6475 East Pacific Coast Highway","address2":"Suite 466","address3":"","address4":"","address5":"","city":"Long Beach","state":"CA","zip":"90803 ","country":"United States","phone":"","tty":"","tollFree":"(844) 762-7672","fax":"","email":"info@hideandseek.org","url":"https://hideandseek.org","freeText":""},{"resourceID":748,"resourceName":"The International Advocates for Glycoprotein Storage Diseases (ISMRD)","abbreviation":"","address1":"20880 Canyon View Drive","address2":"","address3":"","address4":"","address5":"","city":"Saratoga","state":"CA","zip":"95070","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@ismrd.org","url":"https://www.ismrd.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/256550' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=sialidosis%20type%201%5Bti%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Sialidosis type I. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/sialidosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Sialidosis type I. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":267,"resourceId":1104,"resourceName":"American Society of Gene & Cell Therapy -Disease treatment","descriptionText":"The <a href='https://www.asgct.org/education' target='_blank'>American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":282,"resourceId":748,"resourceName":"The International Advocates for Glycoprotein Storage Diseases (ISMRD)","descriptionText":"<a href='http://www.ismrd.org/5th_family_workshop/overview ' target='_blank'>2012 International Conference for Glycoprotein Storage Diseases</a>, July 27, 2012 - July 30, 2012<br /><strong>Location</strong>: Crowne Plaza Hotel, Charleston, SC<br /><strong>Description</strong>: The International Society for Mannosidosis &amp; Related Storage Diseases (ISMRD) is sponsoring the 2012 International Conference for Glycoprotein Storage Diseases. The Scientific/Family meetings will be held concurrently on July 28th and 29th. Alongside this meeting, they are hosting the extension of the Natural History Study, with clinic days on July 27th and 30th.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":869,"resourceId":1575,"resourceName":"RDCRN - Lysosomal Disease Network","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/ldn' target='_blank'>Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br />","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/302/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/mucolipidoses/detail_mucolipidoses.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/948704-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=812' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"}],"overviewQuestion":{"questionId":3783,"questionText":"What is sialidosis type I?","answerText":"Sialidosis is a severe inherited disorder that affects many organs and tissues, including the nervous system. This disorder is divided into two types, which are distinguished by the age at which symptoms appear and the severity of features. <strong>Sialidosis type I </strong>is the less severe form of this condition. People with this condition typically develop signs and symptoms of sialidosis in their teens or twenties.[2673] Characteristic features may include sudden involuntary muscle contractions (<a href=\"http://www.ninds.nih.gov/disorders/myoclonus/detail_myoclonus.htm\" target=\"_blank\">myoclonus</a>), distinctive red spots (cherry-red macules) in the eyes, and sometimes additional neurological findings.[2674] Sialidosis type I is caused by mutations in the <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NEU1\" target=\"_blank\">NEU1</a></em></span> gene.&nbsp;Individuals with sialidosis type I have mutations that result in some functional NEU1 enzyme. The condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.&nbsp;It does not affect intelligence or life expectancy.[2673]","dateModified":"2015-08-13T00:00:00"},"basicQuestions":[{"questionId":3785,"questionText":"How might sialidosis type I be treated?","answerText":"There is no specific treatment for sialidosis. Management should be multidisciplinary and directed at supportive care and symptomatic relief. Overall health maintenance should be a priority, with seizure control as necessary. Myoclonic seizures often respond poorly to treatment with anticonvulsant medications.[2675][2676]","dateModified":"2015-08-13T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2675,"authors":"Roth KS","articleTitle":"Sialidosis (Mucolipidosis I): Treatment & Medication","bookWebsiteJournalTitle":"Medscape Reference","date":"December 13, 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/948704-treatment","dateAccessed":"2015-08-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2676,"authors":"Maire I, Froissart R","articleTitle":"Sialidosis type 1","bookWebsiteJournalTitle":"Orphanet","date":"2007","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=812","dateAccessed":"2015-08-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":28248,"abbreviatedInquiry":"What is sialidosis type I? How might this condition be treated?","caseQuestions":[{"questionId":3783,"questionText":"What is sialidosis type I?","answerText":"Sialidosis is a severe inherited disorder that affects many organs and tissues, including the nervous system. This disorder is divided into two types, which are distinguished by the age at which symptoms appear and the severity of features. <strong>Sialidosis type I </strong>is the less severe form of this condition. People with this condition typically develop signs and symptoms of sialidosis in their teens or twenties.[2673] Characteristic features may include sudden involuntary muscle contractions (<a href=\"http://www.ninds.nih.gov/disorders/myoclonus/detail_myoclonus.htm\" target=\"_blank\">myoclonus</a>), distinctive red spots (cherry-red macules) in the eyes, and sometimes additional neurological findings.[2674] Sialidosis type I is caused by mutations in the <span class=\"geneSymbol\"><em><a href=\"http://ghr.nlm.nih.gov/gene/NEU1\" target=\"_blank\">NEU1</a></em></span> gene.&nbsp;Individuals with sialidosis type I have mutations that result in some functional NEU1 enzyme. The condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> pattern.&nbsp;It does not affect intelligence or life expectancy.[2673]","dateModified":"2015-08-13T00:00:00","references":[{"referenceId":2673,"authors":"","articleTitle":"Sialidosis","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2010","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/sialidosis","dateAccessed":"2015-08-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2674,"authors":"Meikle PJ","articleTitle":"Sialidosis","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2010","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/sialidosis/","dateAccessed":"2015-08-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3785,"questionText":"How might sialidosis type I be treated?","answerText":"There is no specific treatment for sialidosis. Management should be multidisciplinary and directed at supportive care and symptomatic relief. Overall health maintenance should be a priority, with seizure control as necessary. Myoclonic seizures often respond poorly to treatment with anticonvulsant medications.[2675][2676]","dateModified":"2015-08-13T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2675,"authors":"Roth KS","articleTitle":"Sialidosis (Mucolipidosis I): Treatment & Medication","bookWebsiteJournalTitle":"Medscape Reference","date":"December 13, 2013","volume":"","pages":"","url":"http://emedicine.medscape.com/article/948704-treatment","dateAccessed":"2015-08-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2676,"authors":"Maire I, Froissart R","articleTitle":"Sialidosis type 1","bookWebsiteJournalTitle":"Orphanet","date":"2007","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=812","dateAccessed":"2015-08-13T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4003,"phenoTypeName":"Aminoaciduria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12809,"phenoTypeName":"Cherry red spot of the macula","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14402,"phenoTypeName":"Corneal opacity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10703,"phenoTypeName":"Delayed skeletal maturation","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10270,"phenoTypeName":"Dysostosis multiplex","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10287,"phenoTypeName":"Hyperkeratosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13579,"phenoTypeName":"Increased urinary O-linked sialopeptides","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14140,"phenoTypeName":"Pectus carinatum","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5641,"phenoTypeName":"Progressive visual loss","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10492,"phenoTypeName":"Retinopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13169,"phenoTypeName":"Short thorax","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13279,"phenoTypeName":"Skeletal dysplasia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5658,"phenoTypeName":"Slurred speech","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9781,"phenoTypeName":"Thick lower lip vermilion","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1695,"phenoTypeName":"Urinary excretion of sialylated oligosaccharides","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4379,"phenoTypeName":"Vascular skin abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10447,"phenoTypeName":"Wide nasal bridge","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11001,"phenoTypeName":"Abnormal form of the vertebral bodies","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14146,"phenoTypeName":"Decreased nerve conduction velocity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13394,"phenoTypeName":"Frontal bossing","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1860,"phenoTypeName":"Hernia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7902,"phenoTypeName":"Kyphosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4096,"phenoTypeName":"Ascites","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":3616,"phenoTypeName":"Bone-marrow foam cells","percentRanges":"-"},{"phenoTypeId":8971,"phenoTypeName":"Cardiomegaly","percentRanges":"-"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","percentRanges":"-"},{"phenoTypeId":9396,"phenoTypeName":"Dysmetria","percentRanges":"-"},{"phenoTypeId":2795,"phenoTypeName":"Epiphyseal stippling","percentRanges":"-"},{"phenoTypeId":9873,"phenoTypeName":"Facial edema","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","percentRanges":"-"},{"phenoTypeId":3910,"phenoTypeName":"Hydrops fetalis","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":6359,"phenoTypeName":"Inguinal hernia","percentRanges":"-"},{"phenoTypeId":10031,"phenoTypeName":"Proteinuria","percentRanges":"-"},{"phenoTypeId":15556,"phenoTypeName":"Vacuolated lymphocytes","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Sialidosis_type_I"}